These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11361351)

  • 21. Don't just sit there.
    Vazquez E
    Posit Aware; 1996; 7(1):23-5. PubMed ID: 11363119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial.
    de Luis Román DA; Bachiller P; Izaola O; Romero E; Martin J; Arranz M; Eiros Bouza JM; Aller R
    Eur J Clin Nutr; 2001 Dec; 55(12):1048-52. PubMed ID: 11781670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orphan drug for HIV wasting syndrome.
    Am Fam Physician; 1991 Nov; 44(5):1889. PubMed ID: 1950976
    [No Abstract]   [Full Text] [Related]  

  • 24. Cancer cachexia: developing multimodal therapy for a multidimensional problem.
    Fearon KC
    Eur J Cancer; 2008 May; 44(8):1124-32. PubMed ID: 18375115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The cachexia-anorexia syndrome among oncological patients].
    Sosa-Sánchez R; Sánchez-Lara K; Motola-Kuba D; Green-Renner D
    Gac Med Mex; 2008; 144(5):435-40. PubMed ID: 19043964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Balancing the health benefits and the risks of obesity among HIV-infected youth.
    Smit E
    J Am Diet Assoc; 2004 Oct; 104(10):1549-53. PubMed ID: 15389412
    [No Abstract]   [Full Text] [Related]  

  • 27. Nutritional abnormalities in HIV/AIDS.
    Dunn JM
    HIV Hotline; 1998 May; 8(2):11-2. PubMed ID: 11365362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Warding off HIV wasting syndrome.
    Kurtzweil P
    FDA Consum; 1995 Apr; 29(3):16-20. PubMed ID: 10141839
    [No Abstract]   [Full Text] [Related]  

  • 29. Cannabis and cannabidiol: interview with Robert Gorter, M.D. Interview by Fred Gardner.
    Gorter R
    AIDS Treat News; 1998 Oct; (No 305):4-6 concl. PubMed ID: 11365868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
    Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
    Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.
    Joppa MA; Gogas KR; Foster AC; Markison S
    Peptides; 2007 Mar; 28(3):636-42. PubMed ID: 17204351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
    Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
    Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach.
    Pasini E; Aquilani R; Gheorghiade M; Dioguardi FS
    Ital Heart J; 2003 Apr; 4(4):232-5. PubMed ID: 12784775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia.
    Thomas DR
    Clin Nutr; 2007 Aug; 26(4):389-99. PubMed ID: 17499396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease.
    Schols A
    Proc Nutr Soc; 2003 Nov; 62(4):783-91. PubMed ID: 15018476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide and wasting.
    Posit Aware; 1995; VI(6):5. PubMed ID: 11363147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression.
    Nunes EA; Kuczera D; Brito GA; Bonatto SJ; Yamazaki RK; Tanhoffer RA; Mund RC; Kryczyk M; Fernandes LC
    Nutr Res; 2008 Jul; 28(7):487-93. PubMed ID: 19083450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The quality factor.
    HIV Hotline; 1998 May; 8(2):1-6. PubMed ID: 11365361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
    Argilés JM; Busquets S; Felipe A; López-Soriano FJ
    Int J Biochem Cell Biol; 2005 May; 37(5):1084-104. PubMed ID: 15743680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.